DD

Dheeraj Damodar Shanbhag

Active Director Director DIN 11174905
DIN 11174905 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dheeraj Damodar Shanbhag

Data last updated:

Dheeraj Damodar Shanbhag is a Director at Amrutha Life Sciences Private Limited (since 2025). The company operates in Healthcare.

DIN 11174905
Primary Designation Director
Industry Healthcare
First Appointment 01 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20252025Active

Directorship timeline

Open interactive timeline →
Amrutha Life Sciences Private Limited
Premium access

Shareholding and investment profile for Dheeraj Damodar Shanbhag

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dheeraj Damodar Shanbhag

Dheeraj Damodar Shanbhag currently holds 1 directorship: Amrutha Life Sciences Private Limited (Director, since 01 Jul 2025).

Dheeraj Damodar Shanbhag was first appointed on 01 Jul 2025 as Director at Amrutha Life Sciences Private Limited.

The current boards of Dheeraj Damodar Shanbhag's companies include Anil Shivasandra Prabhulingamurthy (Amrutha Life Sciences Private Limited), Humchadakatte Anantha Murthy Pramod Shankar (Amrutha Life Sciences Private Limited), Patil Sachin Vasantrao (Amrutha Life Sciences Private Limited), Satish (Amrutha Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available